
Long-Term Results of the ILLUMINATE-A Trial of Lumasiran for Primary Hyperoxaluria Type 1
0:00
3:54
Dr. Saland summarizes the main findings from his study on "Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Otros episodios de "Clinical Journal of the American Society of Nephrology (CJASN)"



No te pierdas ningún episodio de “Clinical Journal of the American Society of Nephrology (CJASN)”. Síguelo en la aplicación gratuita de GetPodcast.








